Showing results (61-70 of 282) with videos related to
Sort By:
Pageof 29
Current Neuropharmacology|January 6, 2025
In Web We Trust: The Promised Cannabidiol Effects on Obesity as a Matter of Language and Marketing on WebpagesRoberta Roberti, Carla Comacchio, Marco Colizzi, et al.Epilepsia|December 19, 2016
Perampanel effects in the WAG/Rij rat model of epileptogenesis, absence epilepsy, and comorbid depressive-like behaviorRita Citraro, Antonio Leo, Valentina Franco, et al.Journal of Clinical Medicine|October 14, 2022
The Role of the Microbiota Gut-Liver Axis during HCV Chronic Infection: A Schematic OverviewNadia Marascio, Carmen De Caro, Angela Quirino, et al.Expert Review of Neurotherapeutics|October 7, 2020
Practical use of pharmaceutically purified oral cannabidiol in Dravet syndrome and Lennox-Gastaut syndromeSimona Lattanzi, Gaetano Zaccara, Emilio Russo, et al.Journal of Pharmacology & Pharmacotherapeutics|February 25, 2015
Recurrence of atrial fibrillation after switching from brand to generic atenololLuca Gallelli, Francesca Maida, Orietta Staltari, et al.Therapeutic Drug Monitoring|October 19, 2016
Development and Validation of an HPLC-UV Assay for the Therapeutic Monitoring of the New Antiepileptic Drug Perampanel in Human PlasmaValentina Franco, Roberto Marchiselli, Cinzia Fattore, et al.Recent Patents on CNS Drug Discovery|November 28, 2014
Drug-drug interactions: antiretroviral drugs and recreational drugsOrietta Staltari, Christian Leporini, Benedetto Caroleo, et al.Neuropharmacology|July 7, 2012
Ameliorating effects of aripiprazole on cognitive functions and depressive-like behavior in a genetic rat model of absence epilepsy and mild-depression comorbidityEmilio Russo, Rita Citraro, Alessandro Davoli, et al.Expert Opinion on Pharmacotherapy|June 25, 2024
Evaluating bexicaserin for the treatment of developmental epileptic encephalopathiesGiovanni Battista Dell'isola, Alberto Verrotti, Miriam Sciaccaluga, et al.Journal of Pharmacology & Pharmacotherapeutics|December 19, 2013
Safety and efficacy of generic drugs with respect to brand formulationLuca Gallelli, Caterina Palleria, Antonio De Vuono, et al.Pageof 29